Events
BERGENBIO TO PRESENT AT THE UPCOMING 2020 SOLEBURY TROUT VIRTUAL INVESTOR CONFERENCE
Bergen, Norway, March 30, 2020 – BerGenBio, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors…
Read More Mar 31, 2020
Fourth quarter and full year 2019 results presentation and webcast
A presentation by BerGenBio’s senior management will take place 10am CET at: Hotel Continenal, Stortingsgaten…
Read More Feb 11, 2020 Hotel Continenal, Stortingsgaten 24/26, Oslo
BerGenBio to present clinical data from Phase II combination trial of bemcentinib and LDAC trial in elderly AML patients at ASH 2019
Poster presentation at ASH 2019 Date: Monday 9th December 2019 Session Name: 616. Acute Myeloid Leukemia: Novel…
Read More Dec 9, 2019 Orlando, Florida
Third quarter 2019 results presentation and webcast
A presentation by BerGenBio’s will take place 10am CET at: Arctic Securities, Haakon VIIs gate…
Read More Nov 19, 2019 Oslo, Norway
Meet us in Maryland during SITC 2019!
Oral presentation at SITC during High Impact Clinical Trials session: Friday, 8th November 2019: 5:10…
Read More Nov 8, 2019 Maryland
BerGenBio to Present at H.C. Wainwright 21st Annual Global Life Sciences Conference
Meet BerGenBio at the H.C. Wainwright 21st Annual Global Life Sciences Conference 2019 where we…
Read More Sep 10, 2019 New York
Jonas Lies vei 91, 5009 Bergen, Norway
+ 47 559 61 159